Woodman C B, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason T P, Young L S
Centre for Cancer Epidemiology, University of Manchester, Withington, M20 4QL, Manchester, UK.
Lancet. 2001 Jun 9;357(9271):1831-6. doi: 10.1016/S0140-6736(00)04956-4.
Laboratory and epidemiological research suggests an association between human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN). We studied the natural history of incident cervical HPV infection and its relation to the development of CIN.
We recruited 2011 women aged 15-19 years who had recently become sexually active. We took a cervical smear every 6 months and stored samples for virological analysis. We immediately referred all women with any cytological abnormality for colposcopic assessment, but postponed treatment until there was histological evidence of progression to high-grade CIN.
In 1075 women who were cytologically normal and HPV negative at recruitment, the cumulative risk at 3 years of any HPV infection was 44% (95% CI 40-48): HPV 16 was the most common type. The cumulative risk at 3 years of detecting an HPV type not present in the first positive sample was 26% (20-32). 246 women had an abnormal smear during follow-up, of whom 28 progressed to high-grade CIN. The risk of high-grade CIN was greatest in women who tested positive for HPV 16 (risk ratio 8.5 [3.7-19.2]); this risk was maximum 6-12 months after first detection of HPV 16. All HPV types under consideration were associated with cytologically abnormal smears. Although abnormality was significantly less likely to be associated with low-viral-load samples, the cumulative risk at 3 years of a high-viral-load sample after a low-viral-load sample was 45% (95% CI 35-56). Five women who progressed to high-grade CIN consistently tested negative for HPV.
Our findings suggest that attempts to exploit the association between cervical neoplasia and HPV infection to improve effectiveness of cervical screening programmes might be undermined by the limited inferences that can be drawn from the characterisation of a woman's HPV status at a single point in time, and the short lead time gained by its detection.
实验室和流行病学研究表明,人乳头瘤病毒(HPV)与宫颈上皮内瘤变(CIN)之间存在关联。我们研究了新发宫颈HPV感染的自然史及其与CIN发生的关系。
我们招募了2011名年龄在15至19岁之间、近期开始有性行为的女性。我们每6个月进行一次宫颈涂片检查,并储存样本用于病毒学分析。我们立即将所有细胞学异常的女性转诊进行阴道镜评估,但推迟治疗,直到有组织学证据表明进展为高级别CIN。
在1075名招募时细胞学正常且HPV阴性的女性中,3年内任何HPV感染的累积风险为44%(95%CI 40 - 48):HPV 16是最常见的类型。3年内检测到首次阳性样本中未出现的HPV类型的累积风险为26%(20 - 32)。246名女性在随访期间涂片异常,其中28名进展为高级别CIN。HPV 16检测呈阳性的女性发生高级别CIN的风险最高(风险比8.5 [3.7 - 19.2]);这种风险在首次检测到HPV 16后的6至12个月时最高。所有考虑的HPV类型均与细胞学异常涂片有关。虽然异常与低病毒载量样本相关的可能性显著降低,但低病毒载量样本后3年内高病毒载量样本的累积风险为45%(95%CI 35 - 56)。5名进展为高级别CIN的女性HPV检测始终为阴性。
我们的研究结果表明,试图利用宫颈肿瘤与HPV感染之间的关联来提高宫颈筛查计划的有效性,可能会因仅在某一时刻对女性HPV状态进行特征描述所能得出的有限推断以及检测所获得的短提前期而受到影响。